Updated 08:05 GMT, 20 Nov 2026 SPX 7,175.83 -2.02% NDX 26,517.05 -2.21% VIX 28.44 +15.80% GOLD 3,574.90 -3.00% CL 82.63 -0.70% BTC 61,735.58 -0.27%
NAS100 26,517 −2.21% S&P 7,176 −2.02% GOLD $3,575 −3.00% BTC $61,736 −0.27% VIX 28.44 +15.80% latest tape · as of 08:05 UTC
The Screen · Consumer Cyclical · Travel Services

Expedia Group logoExpedia Group

EXPE · a US exchange · USD · Market cap $30.1B · 16,000 employees

Expedia Group, Inc.

PASS · Titan Ethical · score 75.4
239.19 USD

Price as of 19 Nov 2026Daily close, not a live quote

Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price239.19 USD at the 19 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 19 Nov 2026
  • Our regime readDistribution, as of 16 Nov 2026
  • Ethical screenPasses, score 75.4 out of 100
  • OptionsOpen interest leans to puts (put/call 2.49)
  • Last reviewed19 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $409.52 to $478.38, base estimate $412.50 (screen dated 2026-11-19).

Current read
Distribution ?
Undervalued · screened 2026-11-19
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 2.49, read 2026-11-19
  • Ethical passes the values gate
Price239.19 USD
Fair value412.50
Ethical score75.4/100
Value readUndervaluedas of 19 Nov 2026
Our investment reviews on this name
2026-11-11Read Distribution253.77-5.7% to today ✓Markup gives way to Distribution after a 12% slide in 3 weeks
2026-10-18Read Markup288.95-17.2% to today Markdown gives way to Markup after a 9% rise in 7 days
2026-10-11Read Markdown264.23-9.5% to today ✓Distribution gives way to Markdown
2026-10-02Read Distribution264.23-9.5% to today ✓Markup gives way to Distribution after a 5% slide in 9 weeks

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Expedia Group holds its Distribution at $239.19. The statistical read favours the sellers, held for 6 days.

As held on the ledger · 2026-11-19
PhaseDistribution · caution
Quantitative stateThe statistical read favours the sellers, held for 6 days
Price at the screen$239.19
Valuation14.88 trailing · 10.22 forward price to earnings
Values screenPASS · score 75.4
Beta1.39
The Workings

Five Screens: EXPE's Results

PASS. All five recorded results clear their limits.

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 26.24% Below 33% Pass
Interest-bearing cash 1.31% Below 33% Pass
Receivables 39.17% Below 49% Pass
Revenue purity 1.73% Below 5% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Clears, in Plain English

Expedia clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 26%, inside the ~33% line, and interest is about 2% of its income, under the ~5% line, so it passes.

Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when EXPE's ethical verdict changes

Today EXPE passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 19 Nov 2026: it trades at roughly a 42% discount to our $412.50 fair value, narrow competitive moat, 11.90% revenue growth.

Model construction and limits: fair-value methodology.

409.52Conservative412.50Base case478.38Growth case 239.19Price

Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 42.0% discount to the base estimate.

The Street's Range
235.00Street low 330.00Street average 430.00Street high 239.19Price

Third-party analyst targets: 35 covering, consensus Buy. The average target sits +38% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $412.50, with a range of $409.52 to $478.38, dated to the 2026-11-19 screen.

How our estimate and third-party targets differ.

The Business, in Plain Words

Holiday bookings keep the cash flowing

When families finally book that summer holiday, Expedia sits in the middle taking a cut. Revenue is rising 15 percent, the forward multiple sits at just 11.7 times, and return on equity hits 71 percent, all while the shares trade at a 32 percent discount to our fair value. The business clears the ethical screen and still carries a narrow moat in a market where scale matters.

A 10 percent profit margin and buy-rated analyst consensus point to steady demand recovery in travel services. The setup looks attractive on paper for a consumer cyclical name that has rebuilt its balance sheet after the pandemic shock.

Travel spending remains sensitive to recessions and fuel spikes, and a narrow moat leaves room for rivals to chip away at margins. Peak-cycle earnings can flatten fast, so the low multiple may simply reflect that risk rather than a bargain. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E10.2xfairly priced for its growth rate
Trailing P/E14.9xreasonably valued
EPS, trailing17.06
EPS, forward24.82
Revenue growth+11.9%steady growth
Profit margin13.0%thin but positive margins
Return on equity76.7%an exceptional return on shareholder capital
FCF yield7.80%
Dividend yield0.78%
Debt to equity1.95a meaningful debt load worth watching
Current ratio0.77below 1: short-term bills exceed liquid assets
Beta1.39moves a little more than the market
Short interest, float0.09%
52-week range185.34 - 342.00
MoatNARROW
Market cap$30.1B
Employees16,000

EXPE-specific watchpoints · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-18 Distribution $243.16 -4.2% Entry 19

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (33 analysts) rates it buy, with a mean price target of $334.

2026-11-11 Distribution · changed $253.77 -11.2% Entry 18

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 11.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (35 analysts) rates it buy, with a mean price target of $333.

2026-11-04 Markup $285.77 -4.4% Entry 17

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.4% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (34 analysts) rates it buy, with a mean price target of $337. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-03 Markup $298.99 +4.6% Entry 16

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (34 analysts) rates it buy, with a mean price target of $338. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-02 Markup $285.93 +0.0% Entry 15

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (34 analysts) rates it buy, with a mean price target of $338. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-01 Markup $285.93 +0.0% Entry 14

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (34 analysts) rates it buy, with a mean price target of $338. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-31 Markup $285.93 +1.1% Entry 13

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (34 analysts) rates it buy, with a mean price target of $338. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-30 Markup $282.73 +2.6% Entry 12

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (34 analysts) rates it buy, with a mean price target of $338. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-29 Markup $275.53 -4.6% Entry 11

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (34 analysts) rates it buy, with a mean price target of $338. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-28 Markup $288.95 +0.0% Entry 10

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 29%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (34 analysts) rates it buy, with a mean price target of $338. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on EXPE

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in EXPE's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · EXPE
DateInsiderTitleTypeSharesValue
2026-05-15 DILLER BARRY Chairman of the Board 8,185 ·
2026-05-15 ANDERSEN DEREK Chief Financial Officer 7,223 ·
2026-05-15 GORIN ARIANE Chief Executive Officer 16,552 ·
2026-05-15 SOLIDAY LANCE A Officer 1,215 ·
2026-05-15 DZIELAK ROBERT J Officer 5,837 ·
2026-04-15 DZIELAK ROBERT J Officer 2,304 ·
2026-03-13 SCHENKEL SCOTT F Chief Financial Officer 7,626 ·
2026-03-13 DZIELAK ROBERT J Officer 4,631 ·
2026-03-04 DZIELAK ROBERT J Officer 8,225 $1,816,244
2026-02-13 DILLER BARRY Chairman of the Board 9,256 ·

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming EXPE
DatePoliticianPartyTypeAmount
2026-05-27 Ro Khanna Democrat buy 1K–15K
2026-05-15 Ro Khanna Democrat buy 1K–15K
2026-05-06 John Fetterman Democrat buy 1K–15K
2026-05-01 Ro Khanna Democrat buy 1K–15K
2026-04-13 Ro Khanna Democrat Sale 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $291.72 -15.7% · $843 -15.7%
2 months $279.35 -12.0% · $880 -12.0%
3 months $323.70 -24.1% $0.48 $761 -23.9%
6 months $213.89 +14.9% $0.96 $1,154 +15.4%
1 year $238.23 +3.2% $1.84 $1,039 +3.9%
2 years $177.93 +38.1% $3.04 $1,398 +39.8%
3 years $134.52 +82.7% $3.04 $1,850 +85.0%
5 years $172.76 +42.3% $3.04 $1,440 +44.0%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever EXPE does next, these words stay.

Expedia Group · EXPE · Distribution · $239.19
Recorded 2026-11-19 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.